JP2013531477A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531477A5 JP2013531477A5 JP2013509178A JP2013509178A JP2013531477A5 JP 2013531477 A5 JP2013531477 A5 JP 2013531477A5 JP 2013509178 A JP2013509178 A JP 2013509178A JP 2013509178 A JP2013509178 A JP 2013509178A JP 2013531477 A5 JP2013531477 A5 JP 2013531477A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- polypeptide
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000003275 alpha amino acid group Chemical class 0.000 claims 36
- 108090000765 processed proteins & peptides Proteins 0.000 claims 33
- 229920001184 polypeptide Polymers 0.000 claims 32
- 102000004196 processed proteins & peptides Human genes 0.000 claims 32
- 102000007562 Serum Albumin Human genes 0.000 claims 5
- 108010071390 Serum Albumin Proteins 0.000 claims 5
- 230000004927 fusion Effects 0.000 claims 5
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 210000004899 c-terminal region Anatomy 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- 102100037362 Fibronectin Human genes 0.000 claims 2
- 102000002090 Fibronectin type III Human genes 0.000 claims 2
- 108050009401 Fibronectin type III Proteins 0.000 claims 2
- 108010067306 Fibronectins Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 102000009027 Albumins Human genes 0.000 claims 1
- 108010088751 Albumins Proteins 0.000 claims 1
- 102000003973 Fibroblast growth factor 21 Human genes 0.000 claims 1
- 108090000376 Fibroblast growth factor 21 Proteins 0.000 claims 1
- 102000008100 Human Serum Albumin Human genes 0.000 claims 1
- 108091006905 Human Serum Albumin Proteins 0.000 claims 1
- 241000282560 Macaca mulatta Species 0.000 claims 1
- 108020001507 fusion proteins Proteins 0.000 claims 1
- 102000037865 fusion proteins Human genes 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33067210P | 2010-05-03 | 2010-05-03 | |
| US61/330,672 | 2010-05-03 | ||
| US13/098,851 | 2011-05-02 | ||
| US13/098,851 US8969289B2 (en) | 2010-05-03 | 2011-05-02 | Serum albumin binding molecules |
| PCT/US2011/034998 WO2011140086A2 (en) | 2010-05-03 | 2011-05-03 | Serum albumin binding molecules |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015210912A Division JP6219357B2 (ja) | 2010-05-03 | 2015-10-27 | 血清アルブミン結合性分子 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013531477A JP2013531477A (ja) | 2013-08-08 |
| JP2013531477A5 true JP2013531477A5 (OSRAM) | 2014-06-19 |
| JP5876872B2 JP5876872B2 (ja) | 2016-03-02 |
Family
ID=44628186
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013509178A Expired - Fee Related JP5876872B2 (ja) | 2010-05-03 | 2011-05-03 | 血清アルブミン結合性分子 |
| JP2015210912A Expired - Fee Related JP6219357B2 (ja) | 2010-05-03 | 2015-10-27 | 血清アルブミン結合性分子 |
| JP2017185708A Pending JP2018057368A (ja) | 2010-05-03 | 2017-09-27 | 血清アルブミン結合性分子 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015210912A Expired - Fee Related JP6219357B2 (ja) | 2010-05-03 | 2015-10-27 | 血清アルブミン結合性分子 |
| JP2017185708A Pending JP2018057368A (ja) | 2010-05-03 | 2017-09-27 | 血清アルブミン結合性分子 |
Country Status (21)
| Country | Link |
|---|---|
| US (4) | US8969289B2 (OSRAM) |
| EP (1) | EP2566888A2 (OSRAM) |
| JP (3) | JP5876872B2 (OSRAM) |
| KR (1) | KR101854931B1 (OSRAM) |
| CN (2) | CN103003301B (OSRAM) |
| AR (1) | AR081459A1 (OSRAM) |
| AU (1) | AU2011248273B2 (OSRAM) |
| BR (1) | BR112012028162A2 (OSRAM) |
| CA (1) | CA2798510A1 (OSRAM) |
| CL (1) | CL2012003077A1 (OSRAM) |
| CO (1) | CO6630173A2 (OSRAM) |
| EA (1) | EA029334B1 (OSRAM) |
| IL (1) | IL222832A0 (OSRAM) |
| MX (2) | MX346557B (OSRAM) |
| PE (1) | PE20130593A1 (OSRAM) |
| SG (2) | SG185091A1 (OSRAM) |
| TN (1) | TN2012000518A1 (OSRAM) |
| TW (1) | TW201138808A (OSRAM) |
| UY (1) | UY33366A (OSRAM) |
| WO (1) | WO2011140086A2 (OSRAM) |
| ZA (1) | ZA201209091B (OSRAM) |
Families Citing this family (110)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0417302A (pt) | 2003-12-05 | 2007-03-06 | Compound Therapeutics Inc | inibidores de receptores de fator de crescimento endotelial vascular do tipo 2 |
| US8673848B2 (en) | 2012-01-27 | 2014-03-18 | Novartis Ag | Synthetic apelin mimetics for the treatment of heart failure |
| CA2670471A1 (en) | 2006-11-22 | 2008-06-05 | Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| EP2068909B1 (en) | 2007-03-30 | 2012-04-25 | Ambrx, Inc. | Modified fgf-21 polypeptides and their uses |
| JP2011517314A (ja) | 2008-02-14 | 2011-06-02 | ブリストル−マイヤーズ スクイブ カンパニー | Ｅｇｆｒに結合する操作されたタンパク質に基づく標的化された治療薬 |
| CN102099373A (zh) | 2008-05-22 | 2011-06-15 | 百时美施贵宝公司 | 基于纤连蛋白的多价支架结构域蛋白 |
| WO2009158704A2 (en) * | 2008-06-27 | 2009-12-30 | Duke University | Therapeutic agents comprising elastin-like peptides |
| TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子 |
| TW201138808A (en) | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
| EP2576615B1 (en) | 2010-05-26 | 2016-03-30 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins having improved stability |
| US9139629B2 (en) | 2010-06-05 | 2015-09-22 | The Uab Research Foundation | Methods for treatment of nephrotic syndrome and related conditions |
| US9475850B2 (en) * | 2010-06-05 | 2016-10-25 | The Uab Research Foundation | Methods for treatment of nephrotic syndrome and related conditions |
| WO2012116264A1 (en) | 2011-02-24 | 2012-08-30 | The Trustees Of The University Of Pennsylvania | Biomarkers for seizures |
| US9403891B2 (en) * | 2011-03-10 | 2016-08-02 | New York University | Methods and compositions for modulating TNF/TNFR signaling |
| US9469676B2 (en) | 2011-04-13 | 2016-10-18 | Bristol-Myers Squibb Company | Fc fusion proteins comprising novel linkers or arrangements |
| ES2848531T3 (es) | 2011-05-17 | 2021-08-10 | Bristol Myers Squibb Co | Métodos mejorados para la selección de proteínas de unión |
| US20140187488A1 (en) | 2011-05-17 | 2014-07-03 | Bristol-Myers Squibb Company | Methods for maintaining pegylation of polypeptides |
| WO2013009545A1 (en) * | 2011-07-08 | 2013-01-17 | Amylin Pharmaceuticals, Inc. | Engineered polypeptides having enhanced duration of action with reduced immunogenicity |
| WO2013067029A2 (en) | 2011-10-31 | 2013-05-10 | Bristol-Myers Squibb Company | Fibronectin binding domains with reduced immunogenicity |
| EP2827882B1 (en) | 2012-02-21 | 2020-04-08 | Cytonics Corporation | Systems, compositions, and methods for transplantation |
| PL3564258T3 (pl) | 2012-09-13 | 2021-10-25 | Bristol-Myers Squibb Company | Oparte na fibronektynie białka z domeną rusztowania, które wiążą się z miostatyną |
| US8921307B2 (en) | 2012-11-20 | 2014-12-30 | Novartis Ag | Synthetic linear apelin mimetics for the treatment of heart failure |
| UY35144A (es) | 2012-11-20 | 2014-06-30 | Novartis Ag | Miméticos lineales sintéticos de apelina para el tratamiento de insuficiencia cardiaca |
| WO2014100913A1 (en) * | 2012-12-24 | 2014-07-03 | Beijing Anxinhuaide Biotech. Co., Ltd | Improving the half life of a therapeutic polypeptide by fusing with a trimeric scaffold protein via a spacer |
| US20150361159A1 (en) | 2013-02-01 | 2015-12-17 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins |
| EP2953968B1 (en) | 2013-02-06 | 2018-07-25 | Bristol-Myers Squibb Company | Fibronectin type iii domain proteins with enhanced solubility |
| US10065987B2 (en) | 2013-02-12 | 2018-09-04 | Bristol-Myers Squibb Company | High pH protein refolding methods |
| WO2014165093A2 (en) | 2013-03-13 | 2014-10-09 | Bristol-Myers Squibb Company | Fibronectin based scaffold domains linked to serum albumin or a moiety binding thereto |
| AU2014236451B2 (en) * | 2013-03-14 | 2018-08-09 | Regeneron Pharmaceuticals, Inc. | Apelin fusion proteins and uses thereof |
| CN103333255A (zh) * | 2013-06-28 | 2013-10-02 | 复旦大学 | 一种长效hiv‐1膜融合抑制剂 |
| JP2016527249A (ja) | 2013-07-25 | 2016-09-08 | ノバルティス アーゲー | 合成アペリンポリペプチドのバイオコンジュゲート |
| EA201690278A1 (ru) | 2013-07-25 | 2016-06-30 | Новартис Аг | Циклические полипептиды для лечения сердечной недостаточности |
| CN103550790B (zh) * | 2013-11-04 | 2016-01-27 | 上海交通大学医学院附属瑞金医院 | 骨膜蛋白抗体及其在药物制备中的应用 |
| JP6483117B2 (ja) | 2013-11-20 | 2019-03-13 | リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | Ａｐｌｎｒモジュレーター及びその使用 |
| ES2913840T3 (es) | 2014-03-20 | 2022-06-06 | Bristol Myers Squibb Co | Dominios de tipo III de fibronectina de unión a seroalbúmina |
| SG11201607938UA (en) * | 2014-03-27 | 2016-10-28 | Genentech Inc | Methods for diagnosing and treating inflammatory bowel disease |
| KR102854572B1 (ko) | 2014-10-24 | 2025-09-02 | 브리스톨-마이어스 스큅 컴퍼니 | 변형된 fgf-21 폴리펩티드 및 그의 용도 |
| KR20230125855A (ko) | 2014-11-21 | 2023-08-29 | 브리스톨-마이어스 스큅 컴퍼니 | Cd73에 대항한 항체 및 그의 용도 |
| KR102632418B1 (ko) | 2014-11-25 | 2024-01-31 | 브리스톨-마이어스 스큅 컴퍼니 | 영상화를 위한 신규 pd-l1 결합 폴리펩티드 |
| JP6701217B2 (ja) | 2014-11-25 | 2020-05-27 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 生物学的製剤の１８ｆ−放射性標識方法および組成物 |
| CN104587457B (zh) * | 2015-01-13 | 2017-03-22 | 广东海大畜牧兽医研究院有限公司 | 一种利用难溶或不溶蛋白、多肽抗原制备纳米微粒疫苗的方法 |
| CA2972871A1 (en) | 2015-01-23 | 2016-07-28 | Novartis Ag | Synthetic apelin fatty acid conjugates with improved half-life |
| US10849992B1 (en) * | 2015-04-07 | 2020-12-01 | Alector Llc | Methods of screening for sortilin binding antagonists |
| EP3286212B1 (en) * | 2015-04-24 | 2021-06-02 | VIIV Healthcare UK (No.5) Limited | Polypeptides targeting hiv fusion |
| KR102661066B1 (ko) * | 2015-06-12 | 2024-04-25 | 매카이 메디컬 파운데이션 더 프레즈비티리언 처치 인 타이완 매카이 메모리얼 호스피탈 | 면역반응의 조절을 위한 방법 및 항체 |
| WO2017024137A1 (en) * | 2015-08-04 | 2017-02-09 | New York University | Progranulin (pgrn) fragments and derivatives for treatment or alleviation of lysosomal storage diseases |
| JP6893504B2 (ja) * | 2015-09-23 | 2021-06-23 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 速い解離速度を有する血清アルブミン結合フィブロネクチンタイプｉｉｉドメイン |
| WO2017180988A2 (en) | 2016-04-15 | 2017-10-19 | Indiana University Research And Technology Corporation | Fgf21 c-terminal peptide optimization |
| CN109562195A (zh) | 2016-06-01 | 2019-04-02 | 百时美施贵宝公司 | 用pd-l1结合多肽进行pet成像 |
| WO2017210335A1 (en) | 2016-06-01 | 2017-12-07 | Bristol-Myers Squibb Company | Imaging methods using 18f-radiolabeled biologics |
| UA126021C2 (uk) | 2016-06-03 | 2022-08-03 | Янссен Байотек, Інк. | Домен фібронектину типу ііі, що зв'язується із сироватковим альбуміном |
| CN106110325A (zh) * | 2016-06-08 | 2016-11-16 | 上海朗安生物技术有限公司 | 一种新型 glp‑1 受体激动剂的制备方法及其在神经退行性疾病治疗领域的应用 |
| WO2017223180A2 (en) * | 2016-06-21 | 2017-12-28 | Janssen Biotech, Inc. | Cysteine engineered fibronectin type iii domain binding molecules |
| CN107693775A (zh) * | 2016-08-08 | 2018-02-16 | 中国人民解放军沈阳军区总医院 | Creg蛋白用于预防或治疗体重超重、肥胖及其相关疾病的医药用途 |
| WO2018052828A1 (en) * | 2016-09-14 | 2018-03-22 | Janssen Biotech, Inc. | Chimeric antigen receptors comprising bcma-specific fibronectin type iii domains and uses thereof |
| CN110831634B (zh) * | 2017-03-08 | 2024-07-02 | 密歇根大学董事会 | 磷脂酰肌醇蛋白聚糖-3肽试剂和方法 |
| KR102432962B1 (ko) * | 2017-03-16 | 2022-08-12 | 쉔첸 인스티튜트스 오브 어드밴스드 테크놀로지 | 에너지 대사를 조절하는 폴리펩티드 및 그 용도 |
| WO2018165933A1 (zh) * | 2017-03-16 | 2018-09-20 | 深圳先进技术研究院 | 调节糖代谢的多肽及其用途 |
| GB201710973D0 (en) | 2017-07-07 | 2017-08-23 | Avacta Life Sciences Ltd | Scaffold proteins |
| CN111201246B (zh) * | 2017-07-11 | 2023-10-27 | 亚力兄制药公司 | 结合补体成分c5或血清白蛋白的多肽及其融合蛋白 |
| CN109957006B (zh) * | 2017-12-22 | 2021-04-20 | 深圳先进技术研究院 | 一种代谢素多肽人工抗原以及抗体和应用 |
| CN109957005B (zh) * | 2017-12-22 | 2021-04-20 | 深圳先进技术研究院 | 一种代谢素多肽人工抗原及其制备方法、抗体以及应用 |
| KR20210022004A (ko) | 2018-06-18 | 2021-03-02 | 안위타 바이오사이언시스, 인코포레이티드 | 항-메소텔린 작제물 및 이의 용도 |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| WO2020085766A1 (ko) * | 2018-10-24 | 2020-04-30 | 한국과학기술원 | 인간 혈장 알부민에 특이적으로 결합하는 신규한 폴리펩티드 및 이의 용도 |
| JP7652422B2 (ja) | 2018-11-02 | 2025-03-27 | ベイジン ブイディージェイバイオ カンパニー， リミテッド | 修飾されたｃｔｌａ４およびその使用方法 |
| CA3097443A1 (en) * | 2018-11-12 | 2020-05-22 | I-Mab Biopharma Us Limited | Fusion proteins containing cd47 antibodies and cytokines |
| EP3930687A4 (en) | 2019-02-25 | 2023-06-07 | The University of Chicago | METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE CONDITIONS USING ECM AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS |
| US11203614B2 (en) * | 2019-03-25 | 2021-12-21 | Immunwork Inc. | Composite polypeptide having a metal binding motif and molecular construct comprising the same |
| CN109821012A (zh) * | 2019-04-08 | 2019-05-31 | 河南师范大学 | 一种用于治疗代谢疾病的药物组合物及其缓释微球制剂 |
| TWI844709B (zh) * | 2019-07-31 | 2024-06-11 | 美商美國禮來大藥廠 | 鬆弛素(relaxin)類似物及其使用方法 |
| TW202128775A (zh) | 2019-10-16 | 2021-08-01 | 英商阿法克塔生命科學有限公司 | PD-L1抑制劑-TGFβ抑制劑雙特異性藥物部分 |
| CN111965356B (zh) * | 2019-11-28 | 2023-09-08 | 上海荣盛生物药业股份有限公司 | 巯基还原组合物及荧光微球层析试纸和应用 |
| EP4076505A4 (en) * | 2019-12-18 | 2024-01-24 | ARO Biotherapeutics Company | SERUM ALBUM BINDING FIBRONECTIN TYPE III DOMAIN AND USES THEREOF |
| CN113092772A (zh) * | 2019-12-23 | 2021-07-09 | 首都医科大学附属北京世纪坛医院 | 尿液黏连蛋白亚组sa-2及其多肽片段在过敏性疾病中的应用 |
| CN111521812B (zh) * | 2019-12-25 | 2023-02-17 | 瑞博奥(广州)生物科技股份有限公司 | 视神经脊髓炎谱系疾病生物标记物组及其应用和蛋白芯片、试剂盒 |
| WO2021139744A1 (en) | 2020-01-11 | 2021-07-15 | Beijing Ql Biopharmaceutical Co., Ltd. | Conjugates of fusion proteins of glp-1 and fgf21 |
| CN113495147A (zh) * | 2020-03-19 | 2021-10-12 | 首都医科大学附属北京世纪坛医院 | 尿液α2-巨球蛋白及其多肽片段在妊娠糖尿病中的应用 |
| CA3175852A1 (en) * | 2020-04-29 | 2021-11-04 | Onegene Biotechnology Inc. | Novel protein conjugate, and use thereof for preventing or treating nonalcoholic steatohepatitis, obesity and diabetes |
| AU2021280623B9 (en) * | 2020-05-27 | 2024-03-14 | Sciwind Biosciences Co., Ltd. | Interleukin 29 mutant protein |
| CN112694526B (zh) * | 2020-05-27 | 2023-01-20 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体蛋白 |
| GB202101299D0 (en) | 2020-06-09 | 2021-03-17 | Avacta Life Sciences Ltd | Diagnostic polypetides and methods |
| EP4171611A4 (en) * | 2020-07-30 | 2024-10-02 | Anwita Biosciences, Inc. | Interleukin-22 fusion proteins, and their pharmaceutical compositions and therapeutic applications |
| CN114075272B (zh) * | 2020-08-10 | 2023-09-22 | 杭州俊丰生物工程有限公司 | 一种人神经调节蛋白4的制备方法 |
| CN111983241B (zh) * | 2020-09-04 | 2022-05-20 | 四川大学华西医院 | 诊断脑卒中认知障碍的蛋白标志物以及模型的训练方法 |
| CN112321720A (zh) * | 2020-11-05 | 2021-02-05 | 无锡和邦生物科技有限公司 | 一种艾塞那肽人血清白蛋白融合蛋白的纯化方法 |
| CN114848795B (zh) * | 2021-02-03 | 2023-04-14 | 四川大学 | RORa蛋白及其激动剂在制备抗衰老药物中的应用 |
| CN112870336B (zh) * | 2021-02-24 | 2022-06-14 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体蛋白制剂 |
| CN115385998B (zh) * | 2021-04-13 | 2025-08-05 | 杭州先为达生物科技股份有限公司 | 稳定的iii型干扰素蛋白及其融合蛋白 |
| WO2022234003A1 (en) | 2021-05-07 | 2022-11-10 | Avacta Life Sciences Limited | Cd33 binding polypeptides with stefin a protein |
| WO2023284822A1 (en) * | 2021-07-14 | 2023-01-19 | Beijing Ql Biopharmaceutical Co., Ltd. | Fusion polypeptides for metabolic disorders |
| WO2023057567A1 (en) | 2021-10-07 | 2023-04-13 | Avacta Life Sciences Limited | Pd-l1 binding affimers |
| EP4412711A1 (en) | 2021-10-07 | 2024-08-14 | Avacta Life Sciences Limited | Serum half-life extended pd-l1 binding polypeptides |
| CN114288414A (zh) * | 2021-12-07 | 2022-04-08 | 深圳先进技术研究院 | 一种跨血脑屏障的多肽及其衍生物和应用 |
| CN114306630A (zh) * | 2021-12-07 | 2022-04-12 | 深圳先进技术研究院 | 一种靶向脑瘤的多肽及其衍生物和应用 |
| WO2023153876A1 (ko) | 2022-02-10 | 2023-08-17 | 주식회사 아피셀테라퓨틱스 | Cd40l에 특이적으로 결합하는 스테핀 a 단백질 변이체 및 이의 용도 |
| WO2023183932A2 (en) * | 2022-03-25 | 2023-09-28 | New York University | Monobodies binding to intercellular adhesion molecule 2 (icam-2) |
| CN114432429A (zh) * | 2022-04-12 | 2022-05-06 | 中国人民解放军军事科学院军事医学研究院 | 一种预防或治疗骨关节炎的活性分子及其应用 |
| WO2023218243A1 (en) | 2022-05-12 | 2023-11-16 | Avacta Life Sciences Limited | Lag-3/pd-l1 binding fusion proteins |
| CN117645661A (zh) * | 2022-09-02 | 2024-03-05 | 北京志道生物科技有限公司 | 一种聚乙二醇修饰的il-21衍生物及其应用 |
| WO2024051796A1 (en) * | 2022-09-09 | 2024-03-14 | Wuxi Biologics (Shanghai) Co., Ltd. | Albumin binding proteins, fusion proteins and uses thereof |
| CN115433776B (zh) * | 2022-09-30 | 2023-12-22 | 中国医学科学院阜外医院 | Ccn3在调控血管平滑肌细胞钙化中的应用 |
| CN115724951B (zh) * | 2022-11-15 | 2023-10-03 | 怡道生物科技(苏州)有限公司 | 与11型hpv结合的抗体或其抗原结合片段及其应用 |
| EP4652190A1 (en) * | 2023-01-18 | 2025-11-26 | Beijing QL Biopharmaceutical Co., Ltd. | Liquid pharmaceutical compositions of fusion polypeptides and methods of uses thereof |
| TW202432577A (zh) * | 2023-02-10 | 2024-08-16 | 美商拜奧海芬治療學有限公司 | 投與基於纖連蛋白之支架域蛋白以治療超重、肥胖及相關健康病狀 |
| CN121013863A (zh) | 2023-03-31 | 2025-11-25 | 艾菲赛尔治疗株式会社 | Tnfr2结合多肽及使用方法 |
| FR3147292A1 (fr) | 2023-03-31 | 2024-10-04 | Affyxell Therapeutics Co., Ltd. | Cellules genetiquement modifiees dans lesquelles un acide nucleique codant pour des variantes de la proteine stefine a se liant specifiquement au tnfr2 ou une proteine de fusion comprenant celle-ci a ete introduite, et leurs utilisations |
| FR3147278A1 (fr) | 2023-03-31 | 2024-10-04 | Avacta Life Sciences Limited | Polypeptides de liaison au tnfr2 et procedes d'utilisation |
| AU2024277146A1 (en) * | 2023-05-22 | 2025-11-27 | Kaida Biopharmaceuticals, Inc. | Antagonist fusion polypeptides |
| GB202308304D0 (en) | 2023-06-02 | 2023-07-19 | Univ Ulster | A fusion peptide for activation of the apj and/or glp-1 receptors |
Family Cites Families (119)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
| US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
| US6319685B1 (en) | 1984-09-27 | 2001-11-20 | Unigene Laboratories, Inc. | Alpha-amidating enzyme compositions and processes for their production and use |
| US4708934A (en) | 1984-09-27 | 1987-11-24 | Unigene Laboratories, Inc. | α-amidation enzyme |
| GB8516415D0 (en) | 1985-06-28 | 1985-07-31 | Celltech Ltd | Culture of animal cells |
| US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
| US5614492A (en) | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
| US5770697A (en) | 1986-11-04 | 1998-06-23 | Protein Polymer Technologies, Inc. | Peptides comprising repetitive units of amino acids and DNA sequences encoding the same |
| US5641648A (en) | 1986-11-04 | 1997-06-24 | Protein Polymer Technologies, Inc. | Methods for preparing synthetic repetitive DNA |
| US5514581A (en) | 1986-11-04 | 1996-05-07 | Protein Polymer Technologies, Inc. | Functional recombinantly prepared synthetic protein polymer |
| US6018030A (en) | 1986-11-04 | 2000-01-25 | Protein Polymer Technologies, Inc. | Peptides comprising repetitive units of amino acids and DNA sequences encoding the same |
| US5367052A (en) | 1987-04-27 | 1994-11-22 | Amylin Pharmaceuticals, Inc. | Amylin peptides |
| US5789234A (en) | 1987-08-14 | 1998-08-04 | Unigene Laboratories, Inc. | Expression systems for amidating enzyme |
| EP0435911B1 (en) | 1988-09-23 | 1996-03-13 | Cetus Oncology Corporation | Cell culture medium for enhanced cell growth, culture longevity and product expression |
| FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
| WO1992002536A1 (en) | 1990-08-02 | 1992-02-20 | The Regents Of The University Of Colorado | Systematic polypeptide evolution by reverse translation |
| US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
| US5773574A (en) | 1990-12-03 | 1998-06-30 | The Scripps Research Institute | Polypeptides for promoting cell attachment |
| US5235041A (en) | 1990-12-28 | 1993-08-10 | Protein Polymer Technologies, Inc. | Purification of structurally ordered recombinant protein polymers |
| HU222249B1 (hu) | 1991-03-08 | 2003-05-28 | Amylin Pharmaceuticals Inc. | Eljárás amilin agonista peptidszármazékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| US5792742A (en) | 1991-06-14 | 1998-08-11 | New York University | Fibrin-binding peptide fragments of fibronectin |
| US5661007A (en) | 1991-06-25 | 1997-08-26 | Genetics Institute, Inc. | Bone morphogenetic protein-9 compositions |
| US6287816B1 (en) | 1991-06-25 | 2001-09-11 | Genetics Institute, Inc. | BMP-9 compositions |
| AU2313392A (en) | 1991-08-01 | 1993-03-02 | University Research Corporation | Systematic polypeptide evolution by reverse translation |
| PT752248E (pt) | 1992-11-13 | 2001-01-31 | Idec Pharma Corp | Aplicacao terapeutica de anticorpos quimericos e marcados radioactivamente contra antigenios de diferenciacao restrita de linfocitos b humanos para o tratamento do linfoma de celulas b |
| WO1994017097A1 (en) | 1993-01-19 | 1994-08-04 | Regents Of The University Of Minnesota | Synthetic fibronectin fragments as inhibitors of retroviral infections |
| JPH08510205A (ja) | 1993-03-29 | 1996-10-29 | ユニバーシティ オブ シンシナティ | Ｙｙペプチドのアナログとその用途 |
| AU8124694A (en) | 1993-10-29 | 1995-05-22 | Affymax Technologies N.V. | In vitro peptide and antibody display libraries |
| US5559000A (en) | 1995-01-18 | 1996-09-24 | The Scripps Research Institute | Encoded reaction cassette |
| DE19646372C1 (de) | 1995-11-11 | 1997-06-19 | Evotec Biosystems Gmbh | Genotyp und Phänotyp koppelnde Verbindung |
| GB9618960D0 (en) | 1996-09-11 | 1996-10-23 | Medical Science Sys Inc | Proteases |
| US5922676A (en) | 1996-09-20 | 1999-07-13 | The Burnham Institute | Methods of inhibiting cancer by using superfibronectin |
| JP3683282B2 (ja) | 1996-10-17 | 2005-08-17 | 三菱化学株式会社 | 遺伝子型と表現型の対応付け分子及びその利用 |
| US6261804B1 (en) | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
| DE69835143T2 (de) | 1997-01-21 | 2007-06-06 | The General Hospital Corp., Boston | Selektion von proteinen mittels rns-protein fusionen |
| US5830434A (en) | 1997-02-26 | 1998-11-03 | Medical University Of South Carolina Foundation For Research Development | Methods of treating non-insulin dependent diabetes mellitus with pancreatic polypeptide |
| CA2288994C (en) | 1997-04-30 | 2011-07-05 | Enzon, Inc. | Polyalkylene oxide-modified single chain polypeptides |
| EP1958962A3 (en) | 1997-06-12 | 2013-05-01 | Novartis International Pharmaceutical Ltd. | Artificial antibody polypeptides |
| US6159722A (en) | 1997-12-03 | 2000-12-12 | Boehringer Mannheim Gmbh | Chimeric serine proteases |
| US6046167A (en) | 1998-03-25 | 2000-04-04 | University Of Cincinnati | Peptide YY analogs |
| WO1999051773A1 (en) | 1998-04-03 | 1999-10-14 | Phylos, Inc. | Addressable protein arrays |
| DE69934967T2 (de) | 1998-12-08 | 2007-12-06 | Biovation Ltd. | Verfahren zur verminderung der immunogenität von proteinen |
| US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US7115396B2 (en) | 1998-12-10 | 2006-10-03 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| AU775076B2 (en) | 1998-12-10 | 2004-07-15 | Bristol-Myers Squibb Company | Protein scaffolds for antibody mimics and other binding proteins |
| GB9827228D0 (en) | 1998-12-10 | 1999-02-03 | Univ Nottingham | Cancer detection method and reagents |
| US6307024B1 (en) | 1999-03-09 | 2001-10-23 | Zymogenetics, Inc. | Cytokine zalpha11 Ligand |
| MXPA01010891A (es) | 1999-04-28 | 2002-11-07 | Univ Texas | Composiciones y metodos para el tratamiento contra el cancer mediante la inhibicion selectiva del factor de crecimiento endotelial vascular (vegf). |
| US7601691B2 (en) | 1999-05-17 | 2009-10-13 | Conjuchem Biotechnologies Inc. | Anti-obesity agents |
| CA2377468C (en) | 1999-07-27 | 2010-04-20 | Phylos, Inc. | Peptide acceptor ligation methods |
| US20050019826A1 (en) | 2000-03-31 | 2005-01-27 | Roselyne Tournaire | Peptides blocking vascular endothelial growth factor(vegf)-mediated angiogenesis, polynucleotides encoding said pepetides and methods of use thereof |
| AU2001268481A1 (en) | 2000-06-15 | 2001-12-24 | Board Of Regents, The University Of Texas System | Regulatable, catalytically active nucleic acids |
| WO2002004523A2 (en) | 2000-07-11 | 2002-01-17 | Research Corporation Technologies, Inc. | Artificial antibody polypeptides |
| WO2002032925A2 (en) | 2000-10-16 | 2002-04-25 | Phylos, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US7598352B2 (en) | 2000-11-17 | 2009-10-06 | University Of Rochester | Method of identifying polypeptide monobodies which bind to target proteins and use thereof |
| US7556925B2 (en) | 2001-04-04 | 2009-07-07 | University Of Rochester | ανβ3 integrin-binding polypeptide monobodies and their use |
| DK1390535T3 (da) | 2001-04-26 | 2010-12-06 | Amgen Mountain View Inc | Kombinatoriske biblioteker af monomer-domæner |
| WO2003022858A2 (de) | 2001-09-11 | 2003-03-20 | Nascacell Gmbh | Verfahren zum screenen von inhibitoren für die protein-protein-wechselwirkung sowie ribozyme hierzu |
| US20080193445A1 (en) | 2002-01-18 | 2008-08-14 | Liliane Goetsch | Novel anti-IGF-IR antibodies and uses thereof |
| WO2003104418A2 (en) | 2002-06-06 | 2003-12-18 | Research Corporation Technologies, Inc. | Reconstituted polypeptides |
| DE10227232A1 (de) | 2002-06-18 | 2004-01-15 | Aventis Pharma Deutschland Gmbh | Saure Insulinzubereitungen mit verbesserter Stabilität |
| WO2004037995A2 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| BRPI0417302A (pt) | 2003-12-05 | 2007-03-06 | Compound Therapeutics Inc | inibidores de receptores de fator de crescimento endotelial vascular do tipo 2 |
| US20080220049A1 (en) | 2003-12-05 | 2008-09-11 | Adnexus, A Bristol-Myers Squibb R&D Company | Compositions and methods for intraocular delivery of fibronectin scaffold domain proteins |
| WO2006020258A2 (en) | 2004-07-17 | 2006-02-23 | Imclone Systems Incorporated | Novel tetravalent bispecific antibody |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| FR2888850B1 (fr) | 2005-07-22 | 2013-01-11 | Pf Medicament | Nouveaux anticorps anti-igf-ir et leurs applications |
| US7612181B2 (en) | 2005-08-19 | 2009-11-03 | Abbott Laboratories | Dual variable domain immunoglobulin and uses thereof |
| US8097438B2 (en) | 2005-10-07 | 2012-01-17 | The Regents Of The University Of California | Nucleic acids encoding modified cytochrome P450 enzymes and methods of use thereof |
| MX2008006626A (es) | 2005-11-23 | 2008-09-24 | Acceleron Pharma Inc | Antagonistas de activin-actriia y usos para promover el crecimiento de huesos. |
| CN101384279B (zh) | 2006-02-24 | 2012-02-22 | 奇斯药制品公司 | 抗淀粉样蛋白免疫原性组合物、方法和用途 |
| BRPI0710242A2 (pt) | 2006-04-21 | 2011-08-09 | Transgene Sa | uso de uma composição |
| WO2008031098A1 (en) | 2006-09-09 | 2008-03-13 | The University Of Chicago | Binary amino acid libraries for fibronectin type iii polypeptide monobodies |
| CA2666507A1 (en) | 2006-10-16 | 2008-04-24 | The Arizona Board Of Regents, A Body Corporate Of The State Of Arizona A Cting For And On Behalf Of Arizona State University | Synthetic antibodies |
| CA2670471A1 (en) | 2006-11-22 | 2008-06-05 | Adnexus, A Bristol-Myers Squibb R&D Company (A Delaware Corporation) | Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including igf-ir |
| WO2008097497A2 (en) | 2007-02-02 | 2008-08-14 | Adnexus, A Bristol-Myers Squibb R & D Company | Vegf pathway blockade |
| MX2009009379A (es) | 2007-03-02 | 2009-09-14 | Amgen Inc | Metodos y composiciones para tratar enfermedades tumorales. |
| US8470966B2 (en) | 2007-08-10 | 2013-06-25 | Protelica, Inc. | Universal fibronectin type III binding-domain libraries |
| US8680019B2 (en) | 2007-08-10 | 2014-03-25 | Protelica, Inc. | Universal fibronectin Type III binding-domain libraries |
| US20090176654A1 (en) | 2007-08-10 | 2009-07-09 | Protelix, Inc. | Universal fibronectin type III binding-domain libraries |
| US20100285000A1 (en) | 2007-08-20 | 2010-11-11 | Bristol-Myers Squibb Company | Use of vegfr-2 inhibitors for treating metastatic cancer |
| CN101932720A (zh) | 2007-10-31 | 2010-12-29 | 米迪缪尼有限公司 | 蛋白质支架 |
| EP2217274A1 (en) | 2007-11-28 | 2010-08-18 | Bristol-Myers Squibb Company | Combination vegfr2 therapy with mtor inhibitors |
| AU2008345674A1 (en) | 2007-12-19 | 2009-07-09 | Centocor, Ortho Biotech Inc. | Alternative scaffold protein fusions phage display via fusion to pIX of M13 phage |
| CA2710835A1 (en) | 2007-12-27 | 2009-07-09 | Novartis Ag | Improved fibronectin-based binding molecules and their use |
| WO2009102431A1 (en) | 2008-02-12 | 2009-08-20 | Certusview Technologies, Llc | Searchable electronic records of underground facility locate marking operations |
| JP2011517314A (ja) | 2008-02-14 | 2011-06-02 | ブリストル−マイヤーズ スクイブ カンパニー | Ｅｇｆｒに結合する操作されたタンパク質に基づく標的化された治療薬 |
| WO2009133208A1 (en) | 2008-05-02 | 2009-11-05 | Novartis Ag | Improved fibronectin-based binding molecules and uses thereof |
| CN102099373A (zh) | 2008-05-22 | 2011-06-15 | 百时美施贵宝公司 | 基于纤连蛋白的多价支架结构域蛋白 |
| US8415291B2 (en) | 2008-10-31 | 2013-04-09 | Centocor Ortho Biotech Inc. | Anti-TNF alpha fibronectin type III domain based scaffold compositions, methods and uses |
| RS55218B1 (sr) | 2008-10-31 | 2017-02-28 | Janssen Biotech Inc | Kompozicije fibronektin tip iii skalno baziranih domena, metode i upotrebe |
| TWI496582B (zh) | 2008-11-24 | 2015-08-21 | 必治妥美雅史谷比公司 | 雙重專一性之ｅｇｆｒ／ｉｇｆｉｒ結合分子 |
| WO2010069913A1 (en) | 2008-12-16 | 2010-06-24 | Novartis Ag | Yeast display systems |
| EP2396000A1 (en) | 2009-02-11 | 2011-12-21 | Bristol-Myers Squibb Company | Combination vegfr2 therapy with temozolomide |
| MX2011008566A (es) | 2009-02-12 | 2011-11-29 | Janssen Biotech Inc | Composiciones supercontigo basadas en el dominio de fibronectina tipo iii, metodos y usos. |
| US8067201B2 (en) | 2009-04-17 | 2011-11-29 | Bristol-Myers Squibb Company | Methods for protein refolding |
| US20120270797A1 (en) | 2009-08-13 | 2012-10-25 | Massachusetts Institute Of Technology | Engineered proteins including mutant fibronectin domains |
| WO2011051333A1 (en) | 2009-10-30 | 2011-05-05 | Novartis Ag | Universal fibronectin type iii bottom-side binding domain libraries |
| WO2011051466A1 (en) | 2009-11-02 | 2011-05-05 | Novartis Ag | Anti-idiotypic fibronectin-based binding molecules and uses thereof |
| US20110123545A1 (en) | 2009-11-24 | 2011-05-26 | Bristol-Myers Squibb Company | Combination of vegfr2 and igf1r inhibitors for the treatment of proliferative diseases |
| WO2011092233A1 (en) | 2010-01-29 | 2011-08-04 | Novartis Ag | Yeast mating to produce high-affinity combinations of fibronectin-based binders |
| CA2788972A1 (en) | 2010-02-12 | 2011-08-18 | University Of Rochester | Antigenic mimics of discontinuous epitopes of pathogen recognized by broadly neutralizing antibodies |
| US8927693B2 (en) * | 2010-02-18 | 2015-01-06 | Bristol-Myers Squibb Company | Fibronectin based scaffold domain proteins that bind IL-23 |
| US9249508B2 (en) | 2010-03-14 | 2016-02-02 | Mark S. Braiman | Bromine-sensitized solar photolysis of carbon dioxide |
| UY33331A (es) * | 2010-04-13 | 2011-10-31 | Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware | Proteinas de dominio de armazon basadas en fibronectina que se unen a pcsk9 |
| JP2013523179A (ja) | 2010-04-13 | 2013-06-17 | メディミューン，エルエルシー | フィブロネクチンタイプｉｉｉドメインに基づく多量体足場 |
| RU2767543C2 (ru) | 2010-04-30 | 2022-03-17 | Янссен Байотек, Инк. | Композиции на основе стабилизированных фибронектиновых доменов, способы и области их применения |
| TW201138808A (en) | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
| EP2576615B1 (en) | 2010-05-26 | 2016-03-30 | Bristol-Myers Squibb Company | Fibronectin based scaffold proteins having improved stability |
| JP6092773B2 (ja) | 2010-07-30 | 2017-03-08 | ノバルティス アーゲー | フィブロネクチンクレードル分子及びそのライブラリ |
| JP2014504587A (ja) | 2010-12-22 | 2014-02-24 | ブリストル−マイヤーズ スクイブ カンパニー | Ｉｌ−２３に結合するフィブロネクチンをベースとするスカフォールドドメインタンパク質 |
| US9469676B2 (en) | 2011-04-13 | 2016-10-18 | Bristol-Myers Squibb Company | Fc fusion proteins comprising novel linkers or arrangements |
| ES2848531T3 (es) | 2011-05-17 | 2021-08-10 | Bristol Myers Squibb Co | Métodos mejorados para la selección de proteínas de unión |
| US20140187488A1 (en) | 2011-05-17 | 2014-07-03 | Bristol-Myers Squibb Company | Methods for maintaining pegylation of polypeptides |
| US9200273B2 (en) | 2011-09-27 | 2015-12-01 | Janssen Biotech, Inc. | Fibronectin type III repeat based protein scaffolds with alternative binding surfaces |
| ES2913840T3 (es) | 2014-03-20 | 2022-06-06 | Bristol Myers Squibb Co | Dominios de tipo III de fibronectina de unión a seroalbúmina |
| JP6893504B2 (ja) * | 2015-09-23 | 2021-06-23 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | 速い解離速度を有する血清アルブミン結合フィブロネクチンタイプｉｉｉドメイン |
-
2011
- 2011-04-29 TW TW100115218A patent/TW201138808A/zh unknown
- 2011-05-02 US US13/098,851 patent/US8969289B2/en active Active
- 2011-05-03 CN CN201180033246.3A patent/CN103003301B/zh not_active Expired - Fee Related
- 2011-05-03 UY UY0001033366A patent/UY33366A/es not_active Application Discontinuation
- 2011-05-03 EP EP11730481.6A patent/EP2566888A2/en not_active Withdrawn
- 2011-05-03 KR KR1020127031428A patent/KR101854931B1/ko not_active Expired - Fee Related
- 2011-05-03 AU AU2011248273A patent/AU2011248273B2/en not_active Ceased
- 2011-05-03 SG SG2012080032A patent/SG185091A1/en unknown
- 2011-05-03 AR ARP110101521A patent/AR081459A1/es unknown
- 2011-05-03 SG SG10201503366XA patent/SG10201503366XA/en unknown
- 2011-05-03 MX MX2015004831A patent/MX346557B/es unknown
- 2011-05-03 CN CN201610756654.6A patent/CN107698682A/zh active Pending
- 2011-05-03 MX MX2012012800A patent/MX2012012800A/es active IP Right Grant
- 2011-05-03 BR BR112012028162-3A patent/BR112012028162A2/pt not_active IP Right Cessation
- 2011-05-03 CA CA2798510A patent/CA2798510A1/en not_active Abandoned
- 2011-05-03 WO PCT/US2011/034998 patent/WO2011140086A2/en not_active Ceased
- 2011-05-03 EA EA201270775A patent/EA029334B1/ru not_active IP Right Cessation
- 2011-05-03 PE PE2012002119A patent/PE20130593A1/es not_active Application Discontinuation
- 2011-05-03 JP JP2013509178A patent/JP5876872B2/ja not_active Expired - Fee Related
-
2012
- 2012-10-30 TN TNP2012000518A patent/TN2012000518A1/en unknown
- 2012-10-31 CL CL2012003077A patent/CL2012003077A1/es unknown
- 2012-11-01 CO CO12197670A patent/CO6630173A2/es not_active Application Discontinuation
- 2012-11-01 IL IL222832A patent/IL222832A0/en active IP Right Grant
- 2012-11-30 ZA ZA2012/09091A patent/ZA201209091B/en unknown
-
2014
- 2014-11-25 US US14/552,823 patent/US9540424B2/en active Active
-
2015
- 2015-10-27 JP JP2015210912A patent/JP6219357B2/ja not_active Expired - Fee Related
-
2016
- 2016-11-29 US US15/363,724 patent/US10221438B2/en active Active
-
2017
- 2017-09-27 JP JP2017185708A patent/JP2018057368A/ja active Pending
-
2019
- 2019-01-10 US US16/244,921 patent/US10934572B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013531477A5 (OSRAM) | ||
| JP2016052315A5 (OSRAM) | ||
| JP2010068806A5 (OSRAM) | ||
| JP2014506790A5 (OSRAM) | ||
| JP2018532725A5 (OSRAM) | ||
| JP7501356B2 (ja) | 融合タンパク質 | |
| JP2015525217A5 (OSRAM) | ||
| JP2013027391A5 (OSRAM) | ||
| FI2968461T3 (fi) | Fuusioproteiineja, jotka käsittävät pdgf:ää ja vegf:ää sitovia osia, ja menetelmiä niiden käyttämiseksi | |
| JP2016000731A5 (OSRAM) | ||
| JP2019516663A5 (OSRAM) | ||
| JP2005120106A5 (OSRAM) | ||
| IL275497B (en) | Serum proteins with type iii fibronectin binding domains | |
| JP2007513634A5 (OSRAM) | ||
| JP2018537087A5 (OSRAM) | ||
| JP2010273685A5 (OSRAM) | ||
| JP2017512063A5 (OSRAM) | ||
| Abdelhamid et al. | Application of volcanic ash particles for protein affinity purification with a minimized silica-binding tag | |
| JP2016530236A5 (OSRAM) | ||
| JP2014502504A (ja) | 植物において組換えタンパク質を発現および精製するための費用効果が高い方法 | |
| JP2015524403A5 (OSRAM) | ||
| JP2018524019A5 (OSRAM) | ||
| CN114773484A (zh) | 吸附细胞因子的重组融合蛋白、纳米组装体及其制备方法与应用 | |
| JP2014517690A5 (OSRAM) | ||
| JP2009513118A5 (OSRAM) |